In the present study we Also there is no agreement on the maximum number of liver metastases that will justify partial liver resection for cure. Clearly, there is a need for prospective randomized trials on which a more rational policy regarding hepatic metastases in colorectal cancer patients can be based.
INTRODUCTION
Colorectal cancer is the second leading cause of death from cancer1. Although 75% of colorectal cancer patients will have a primary surgical resection for cure, nearly half of all patients with colorectal cancer still die of metastatic tumor2. Resection of liver metastases and adjuvant chemotherapy are currently the most promising developments in the treatment of colorectal cancer patients.
Because there exists worldwide controversy among clinicians regarding optimal diagnostic and thera-* Correspondence to: J. Kievit (Table 3 ).
The number of liver resections per hospital has also (Table  6 ). This is mainly caused by an increase in the use of chemotherapy in France and the UK. The average number of patients treated with chemotherapy per hospital, however, has dropped from 18 to 12 per year (Table 7 ). In addition, a shift from local adminisatration towards systemic administration of chemotherapy was observed. 
